PREGNANCY COMPLICATED BY THE ANTIPHOSPHOLIPID SYNDROME

被引：10

作者：

MUNDAY, DN

JONES, WR

机构：

[1] Department of Obstetrics and Gynaecology, Flinders Medical Centre, Adelaide

来源：

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY | 1993年 / 33卷 / 03期

关键词：

D O I：

10.1111/j.1479-828X.1993.tb02079.x

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

A patient with previously undiagnosed antiphospholipid syndrome (APS) developed atypical severe preeclampsia at 31 weeks' gestation. Other complications of pregnancy included intrauterine growth retardation, thrombocytopenia and fetal distress necessitating urgent delivery of a live infant. There was a prior history of unexplained jugular venous thrombosis. Prophylaxis against thrombosis was commenced immediately postoperatively and no postpartum complications occurred. Recent evidence supports the use of antepartum prophylaxis with low dose heparin in patients with APS. The role of low dose aspirin, either alone or in combination with heparin, is yet to be determined. Human immunoglobulin may be useful in selected cases. Early diagnosis is a key factor in their management.

引用

页码：255 / 258

页数：4

共 15 条

[1]

Branch DW, Andres R, Digre KB, Rote NS, Scott JR, The Association of Antiphospholipid Antibodies with Severe Pre‐eclampsia, Obstet Gynecol, 73, pp. 541-545, (1989)

[2]

Katz VL, Throp JM, Watson WJ, Fowler L, Heine RP, Human Immunoglobulin Therapy for Preeclampsia associated with Lupus Anticoagulant and Anticardiolipin Antibody, Obstet Gynecol, 76, pp. 986-988, (1990)

[3]

Ayres MA, Sulak PJ, Pregnancy Complicated by Antiphospholipid Antibodies, South Med J, 84, pp. 266-269, (1991)

[4]

Rao AA, Ananthakrishna NC, Anticardiolipin antibodies in eclampsia, Int J Gynecol Obstet, 38, pp. 37-40, (1992)

[5]

Harris NE, Maternal autoantibodies and pregnancy ‐ I: The antiphospholipid antibody syndrome, Baillieres Clin Rheumatol, 4, pp. 53-68, (1990)

[6]

Branch DW, Antiphospholipid Antibodies and Pregnancy: Maternal Implications, Semin Perinatal, 14, pp. 139-146, (1990)

[7]

Lubbe WF, Liggins GC, Lupus anticoagulant and pregnancy, Am J Obstet Gynecol, 153, pp. 322-327, (1985)

[8]

Triplett DA, Brandt JT, Kazcor D, Et al., Laboratory diagnosis of lupus inhibitors: A comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure, Am J Clin Pathol, 79, pp. 678-682, (1983)

[9]

Lockshin MD, Druzin ML, Goli S, Et al., Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus ertyhematosus, N Engl J Med, 313, pp. 152-156, (1985)

[10]

Birdsall M, Pattison N, Chamley L., Antiphospholipid Antibodies in Pregnancy, Aust NZ J Obstet Gynaecol, 32, pp. 328-330, (1992)

← 1 2 →